ENTITY

IN8bio (INAB US)

8
Analysis
Health Care • United States
IN8bio, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. IN8bio serves customers in the United States.
more
Company Event • 14 Mar 2026 04:00 • Upcoming
Add To Calendar
Company Event • 06 Nov 2025 20:00 • Upcoming
Add To Calendar
Company Event • 07 Aug 2025 19:00 • Upcoming
Add To Calendar
Company Event • 08 May 2025 04:00 • Upcoming
Add To Calendar
Company Event • 14 Mar 2025 04:00 • Upcoming
Add To Calendar
x